This course is included in the NUTRITION 2025 Obesity Collection.

Recently developed anti-obesity medications have revolutionized obesity treatment with significant weight loss outcomes. This engaging session explores the vital nutritional considerations for individuals on these medications. Attendees will gain insights into the evaluation, management, and follow-up strategies that optimize nutritional care for patients with obesity, ensuring lasting success throughout their weight loss therapy. 
 
This session also includes a discussion of Nutritional Priorities to Support GLP-1 Therapy for Weight Loss: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. 

Originally presented at NUTRITION 2025, ASN's flagship meeting which was held May 31 to June 3 in Orlando, FL.

Speakers

Monica Agarwal, MD, MEHP, PNS, FACE
University of Alabama at Birmingham

Jaime Almandoz, MD, MBA, MRCPI, FTOS
UT Southwestern Medical Center

Jamy D. Ard, MD
Wake Forest School of Medicine, Department of Epidemiology and Prevention

Christos S. Katsanos, PhD
Arizona State University

Learning Objectives

• Describe nutritional risks and body composition changes associated with GLP-1 RA obesity medications 
• Perform baseline assessments to guide individualized nutrition recommendations 
• Apply strategies to manage GI side effects and support adequate nutrient intake 
• Integrate physical activity and multidisciplinary support into obesity care